Long-term clinical effectiveness of a drug-coated balloon for in-stent restenosis in Femoropopliteal lesions
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2520-8934
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Long-term clinical effectiveness of a drug-coated balloon for in-stent restenosis in Femoropopliteal lesions ; volume:4 ; number:1 ; day:11 ; month:1 ; year:2021 ; pages:1-9 ; date:12.2021
CVIR endovascular ; 4, Heft 1 (11.1.2021), 1-9, 12.2021
- Urheber
-
Horie, Kazunori
Tanaka, Akiko
Suzuki, Kenji
Taguri, Masataka
Inoue, Naoto
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s42155-021-00205-x
- URN
-
urn:nbn:de:101:1-2021030218070629635463
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:37 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Horie, Kazunori
- Tanaka, Akiko
- Suzuki, Kenji
- Taguri, Masataka
- Inoue, Naoto
- SpringerLink (Online service)
Ähnliche Objekte (12)
Rotarex®S rotational atherectomy combined with drug-coated balloon angioplasty for treating femoropopliteal artery in-stent restenosis
Drug-coated balloon treatment for Femoropopliteal artery disease: The IN.PACT Global study de novo in-stent restenosis imaging cohort
Evaluation of femoropopliteal in-stent restenosis characteristics stratified by stent design
Analysis of the incidence and influencing factors associated with binary restenosis of target lesions after drug-coated balloon angioplasty for patients with in-stent restenosis
Determinants of drug-coated balloon failure in patients undergoing femoropopliteal arterial intervention
Drug-Coated Balloons for Restenosis Prophylaxis
In-stent restenosis in real world
5-Year outcomes of drug-coated balloons for peripheral artery in-stent restenosis, long lesions, and CTOs
Impact of Chocolate percutaneous transluminal angioplasty balloon on vessel preparation in drug-coated balloon angioplasty for femoropopliteal lesion
Drug-coated balloon versus drug-eluting stent for femoropopliteal total occlusions: intraluminal versus subintimal approaches
Repeat drug-coated balloon angioplasty for femoropopliteal lesions: 12-month results from a retrospective observational study
Platelet to lymphocyte ratio predicting 6-month primary patency of drug-coated balloon for femoropopliteal disease
Rotarex®S rotational atherectomy combined with drug-coated balloon angioplasty for treating femoropopliteal artery in-stent restenosis
Drug-coated balloon treatment for Femoropopliteal artery disease: The IN.PACT Global study de novo in-stent restenosis imaging cohort
Evaluation of femoropopliteal in-stent restenosis characteristics stratified by stent design
Analysis of the incidence and influencing factors associated with binary restenosis of target lesions after drug-coated balloon angioplasty for patients with in-stent restenosis
Determinants of drug-coated balloon failure in patients undergoing femoropopliteal arterial intervention
Drug-Coated Balloons for Restenosis Prophylaxis
In-stent restenosis in real world
5-Year outcomes of drug-coated balloons for peripheral artery in-stent restenosis, long lesions, and CTOs
Impact of Chocolate percutaneous transluminal angioplasty balloon on vessel preparation in drug-coated balloon angioplasty for femoropopliteal lesion
Drug-coated balloon versus drug-eluting stent for femoropopliteal total occlusions: intraluminal versus subintimal approaches
Repeat drug-coated balloon angioplasty for femoropopliteal lesions: 12-month results from a retrospective observational study
Platelet to lymphocyte ratio predicting 6-month primary patency of drug-coated balloon for femoropopliteal disease
Rotarex®S rotational atherectomy combined with drug-coated balloon angioplasty for treating femoropopliteal artery in-stent restenosis
Drug-coated balloon treatment for Femoropopliteal artery disease: The IN.PACT Global study de novo in-stent restenosis imaging cohort
Evaluation of femoropopliteal in-stent restenosis characteristics stratified by stent design
Analysis of the incidence and influencing factors associated with binary restenosis of target lesions after drug-coated balloon angioplasty for patients with in-stent restenosis
Determinants of drug-coated balloon failure in patients undergoing femoropopliteal arterial intervention
Drug-Coated Balloons for Restenosis Prophylaxis
In-stent restenosis in real world
5-Year outcomes of drug-coated balloons for peripheral artery in-stent restenosis, long lesions, and CTOs
Impact of Chocolate percutaneous transluminal angioplasty balloon on vessel preparation in drug-coated balloon angioplasty for femoropopliteal lesion
Drug-coated balloon versus drug-eluting stent for femoropopliteal total occlusions: intraluminal versus subintimal approaches
Repeat drug-coated balloon angioplasty for femoropopliteal lesions: 12-month results from a retrospective observational study